In 2023, we are watching the market reaction. What are the Part D plans doing now as they prepare for the changes coming in 2025 when they are on the hook for a greater percentage of spending on Part D benefit.
Vice President and Head of Federal and State Policy
Lindsay leads ADVI’s policy team and guides legislative, regulatory and market access efforts across payers for clients spanning the pharmaceutical, biotechnology, device, diagnostic and digital health industries, as well as physician practices and specialty societies.
Director of Federal and State Policy
Brenna leads ADVI’s initiatives in policy and reimbursement, serving biopharmaceutical clients and projects.
We look forward to hearing from you and discussing how these issues are relevant to your business needs.
Stay ahead of the curve. Get in touch today to gain expert insights into the IRA and the evolving healthcare landscape.